Long COVID, ME/CFS and Chronic Illnesses – Strategic Moves in a 360° Perspective
Effectively addressing Long COVID, ME/CFS, and other chronic illnesses requires a multifaceted and interdisciplinary approach. Our "chessboard" the healthcare and research landscape, must be occupied by numerous key players to enable a comprehensive and effective solution.
Based on a holistic examination of disease mechanisms, I have compiled an initial selection of relevant "players." This list is by no means exhaustive but represents a curated overview that illustrates the broad spectrum of potential strategies and interventions.
The 360-degree perspective was deliberately chosen to systematically encompass all crucial aspects, strategically pursuing the goal of checkmating these diseases. It will require numerous targeted moves, but I firmly believe that — both medically and societally — we can overcome these challenges if we maintain a comprehensive and integrative approach.
The order of the mentioned stakeholders does not imply a ranking, all participants are equally vital
Long COVID, ME/CFS und chronische Erkrankungen – Strategische Spielzüge im 360°-Blickwinkel
Die erfolgreiche Bewältigung von Long COVID, ME/CFS und anderen chronischen Erkrankungen erfordert ein vielschichtiges und interdisziplinäres Vorgehen. Unser „Schachfeld“ – der Gesundheits- und Forschungsbereich – muss mit zahlreichen Akteuren besetzt sein, um eine ganzheitliche und wirksame Lösung zu ermöglichen.
Auf Grundlage einer umfassenden Betrachtungsweise der Krankheitsmechanismen habe ich eine erste Auswahl relevanter „Spieler“ zusammengestellt. Diese Liste ist keineswegs abschließend, sondern stellt lediglich eine repräsentative Auswahl dar, die das breite Spektrum möglicher Lösungsansätze verdeutlichen soll.
Bewusst wurde der Ansatz aus einer 360-Grad-Perspektive gewählt, um alle relevanten Aspekte systematisch zu erfassen und das Ziel eines Schachmatts gegen diese Krankheiten strategisch zu verfolgen. Es wird zahlreiche gezielte Spielzüge benötigen, doch ich bin überzeugt, dass wir es – sowohl aus medizinischer als auch aus gesellschaftlicher Perspektive – gemeinsam bewältigen können, wenn wir den ganzheitlichen Blickwinkel beibehalten.
Die Reihenfolge der genannten Akteure stellt keine Wertung dar – alle Beteiligten sind gleichberechtigt und spielen eine essenzielle Rolle in diesem strategischen Prozess.
(M)eine kleine Auswahl von "Spielern" / My small selection of “players” (This list could go on indefinitely)
1. Professor CHAN Chun Yong, Eric BSc (Pharm) (Hons), PhD, Singapore – a real pioneering role with its PK Weekly Dose on LinkedIN
2. Medical Medium (Anthony William) - Many millions of people follow and live by it
4. Professor David F. Putrino (Long Covid specialist and neuroscientist - Mount Sinai/New York)
5. Dr. William Wallace, Ph.D (LinkedIn/Instagram)
6. YouScript: Kristine Ashcraft – PGX / Personalized Medicine
7. Dr. Amine Zorgani – The Microbiome Mavericks
8. PRECISEU project - Horizon Europe (25 partners from 12 European region)
9. Frank Bernier, PhD
10. Professor Yohannes Hagos (PortaCellTech)
11. Professor Henk-Jan-Guchelaar
12. Professor Erwin Loh
13. Michael F. Hughes (Supervisory Toxicologist at US Environmental Protection Agency (EPA))
14. Professor Dr. med. Carmen Scheibenbogen (Charité Berlin)
15. Professor Dr. Uta Behrends (TUM München)
16. Daniel Epstein
18. Professor Dr. Robert Murphy (Freiburg)
19. Professor Magnus Ingelmann-Sundberg
20. Dr. Shilpa Thakur, Ph.D Medical Nutrition
21. Kent Jones (Multiple sclerosis guerilla and Accessibility advocate)
22. Professor Dr. Hannelore Daniel
23. Chris Methmann, Food Watch / Food Watch France
24. Zeyad Ibrahim
25. Ryan Stoffko (OPP NEURO-SPA's mission)
26. Evonne Fouesnant
27. Dr. Eric Topol
28. Professor Kevin Kavanagh
29. Professor Dr. Ron Davis
30. Dr. Lisa Sanders (Yale)
31. David Tuller, DrPH
32. Peter Groenen (Biomarker Expert)
33. Miguel Angel Cabrera-Pérez
34. Dr. Lyle D. Burgoon (Professor, Institute for Integrative Toxicology)
35. Dr. Maureen Miller (a Columbia University infectious disease epidemiologist and medical anthropologist targeting systems level change)
36. Professor Jianzhong Wang (College of Veterinary Medicine, China Agricultural University)
37. Professor Antonella Bertazzo (Food Chemistry, Nutritional Science - University of Padua)
38. Professor Youssef Daali (University of Geneva: Anesthesiology, Pharmacology, Intensive Care and Emergencies)
39. Professor Ram Shankar Upadhayaya (Uppsala University)
40. Christoph & Philipp Ströck - WE&ME Stiftung - Österreich
41. Shelby Coates, PhD (Washington)
42. My Long Covid Advocacy
43. Janice Goh – Development of coffee simulator
44. Dotan Shaniv (Israel)
45. Nita Jain (Illuminating Biological Complexity)
47. Dr. Uwe Gröber is one of the leading micronutrient experts in the German-speaking world
48. Cohen Center for Recovery From Complex Chronic Illnesses (Mount Sinai)
50. American Academy of Clinical Toxicology (AACT)
51. Nanotechnology (Institute for Tissue Engineering and Regenerative Medicine, Helmholtz Munich)
52. University College London (Pharmacology and Toxicology)
53. Zhejiang University (China)
54. University of Montreal (Canada)
55. NYSIM a center for simulation education in the health sciences at CUNY & NYU Langone Health
56. CeMM (Wien)
57. NIH - National Institutes of Health
58. FEAM (Brüssel)
59. PAN Germany / Pesticide Action Network
60. FDA / EMA / CPIC / PharmVar, health research, pharmacovigilance, (Specialist) committees / BioBank Graz / Shanghai Zhangjiang Biobank
61. Munich Environmental Institute
63. Luoheng Qin, InSilico Medicine
64. Mayo Clinic
65. University of Cambridge
68. Förderverein OrphanHealthcare (Dr. Frank Grossmann)
69. Disaster management strategies for Long Covid, ME/CFS and MCS
70. Frontiers
71. Solution Group (Beijing) Company
72. Memorial Healthcare system
74. Kmch Research Foundation
75. BAYER
76. vfa - research-based pharmaceutical companies
77. MedWatch (FDA / USA)
78. European database of reported adverse reactions / EudraVigilance
79. Software and technology companies, start-ups
80. The many valuable patient organizations and associations, Healthcare providers, pharmacists/Pharmacists' associations, Healthcare providers, pharmacists, biobanks, insurers, health insurance companies, MedSafetyWeek organizers, fellows, investors, angel and venture communities, Environmental physicians, biomedical scientists
81. Pharmaceutical and vaccine manufacturers and developers (From A for AbbVie to V for ViiV Healthcare GmbH), MedTech Pharma
82. Educational institutions, lawyers, authorities, security forces, inistries
83. all international environmental organizations/institutions
AND EVERY ONE OF US
Wollen Sie mehr über meine Ökosysteme "Personalisierte Medizin und PGx" im 360-Blick-Winkel erfahren? Would you like to find out more about my “Personalized Medicine and PGx” ecosystems from a 360° perspective?
Folgen Sie mir / Follow me: Version Deutsch / Version English